MarkosWeb

covid-19 widget

faslodex.com

FASLODEX fulvestrant Injection 500 mg Metastatic Breast Cancer Treatmen...

edit
Official patient Web site for FASLODEX fulvestrant Injection 500 mg a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer



Rating:
5 of 5 (1 votes)
Links from homepages:
17 links (from 8 hosts)
updated November 6, 2013
Homepage links:
internal 39, external 0
Unique visitors:
1,365 ( 258)
diff as of July 1, 2013
Snapshot history:
7 available via snapshot tool
Title history:
1 changes recorded
HTML validation:
Error
DNS resolve:
OK
Domain worth:
$37,735
Health score:
36.33%
Domain registrar:
CSC CORPORATE DOMAINS, INC. domain profile
Domains using same registrar:22,578

Technical

Website availability: (is site down?)

Latest result: Website is UP

Latest test time and date: 6:01:22 PM November 5, 2013

Latest test duration: 0.128 seconds


Test results (detailed CURL answer)
HTML size: 28799 bytes
Url: http://www.faslodex.com/index.aspx
Content_type: text/html; charset=utf-8
Http_code: 200
Header_size: 807
Request_size: 356
Filetime: -1
Redirect_count: 1
Total_time: 0.126193
Namelookup_time: 0.035097
Connect_time: 0.043878
Pretransfer_time: 0.043903
Size_download: 28799
Speed_download: 228213
Download_content_length: 28799
Starttransfer_time: 0.058465
Redirect_time: 0.023569
Used technologies:
Javascript frameworks
jQuery (version 1.4.4)
Miscellaneous
SWFObject
Operating systems
Windows Server
Web frameworks
Microsoft ASP.NET (version 2.0.50727)
Web servers
IIS (version 6.0)
Hosting:
Verizon Business (MCI Communications Services, Inc. d/b/a Verizon Business)
Hosting abuse phone:
office +1-800-900-0241
Hosting abuse mail:
Domain IP:
164.109.33.26 United States
DNS Resolve:
OK
Name server (NS) records:
dns1.cscdns.net (IP 209.112.114.33)
Other domains using this NS: 4,212
dns2.cscdns.net (IP 69.36.145.33)
Other domains using this NS: 4,212
NS history:
1 changes since September 15, 2011
September 15, 2011 nsgbr.comlaude.co.uk
nssui.comlaude.ch
nsusa.comlaude.net
dns1.cscdns.net
dns2.cscdns.net
Public registrar record:

Profile

Unique visitors:
1,365 ( 258)
diff as of July 1, 2013
Domain age:
22 years and 11 months
Domain worth:
$37,735
Health score:
36.33%
Domain score widget:
Domain worth widget:
MarkosWeb certification:

Social #faslodex.com

Social activity: updated 1 Jul 2014
MarkosWeb reviews:

Advertising

AdSense Checker: (AdSense Checker:)
Is domain banned from using Google Adsense?
Tags prominence:
(important page elements, estimated advertising value)
injection (30%, $1.73), breast cancer (28%, $3.54), breast cancer treatment (20%, $9.40), cancer treatment (20%, $4.94), breast cancer information (1%, $6.65)
Ads SERP visibility: based on research of 16,000,000 keywords

Geography

Audience location:
Minimum required screen width is 768 - Please use other device to view
SERP organic visitors pie
Visualizes local performance of organic positions. Positions visibility distribution is presented by Country showing each country's share in %

    SEO

    Homepage links:
    internal 39, external 0
    Title history:
    1 changes recorded
    HTML validation:
    Error
    Title:
    FASLODEX fulvestrant Injection 500 mg Metastatic Breast Cancer Treatment
    Meta-keywords:
    FASLODEX fulvestrant injection metastatic breast cancer treatment hormone receptor-positive therapy
    Meta-description:
    Official patient Web site for FASLODEX fulvestrant Injection 500 mg a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer
    MarkosWeb Domain RSS:
    Get the latest updates on faslodex.com via RSS
    SERP organic visibility: based on research of 16,000,000 keywords
    Domain name is seen on 131 search engine queries. Average position in SERP is 21. Best position in SERP for this domain is #1 (it's found 3 times). Statistical information was collected from April 20, 2012 to April 22, 2012
    SERP organic rankings distribution:
    Visualizes organic positions distribution for domain pages that were found in top 40 results.